Natus Medical Launches neoBLUE Mini LED Phototherapy Device

Natus Medical Incorporated ("Natus") (Nasdaq:BABY) today announced the addition of the new neoBLUE mini(TM) LED Phototherapy device to the Company's line of jaundice management products. Natus recently previewed the neoBLUE mini system at the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) Convention in Tampa, Florida, where it was well received. The international launch of the neoBLUE mini light is scheduled to take place September 18, 2004 at the European Society of Paediatric Research meeting in Stockholm, Sweden.

Designed as a smaller counterpart to Natus' existing overhead neoBLUE(TM) LED Phototherapy Light, the neoBLUE mini system offers clinicians a more compact and portable alternative to other brands of phototherapy devices currently on the market. The neoBLUE mini device's adjustable arm with pole mount facilitates attachment to a variety of patient care apparatuses such as incubators and radiant warmers, often used during phototherapy treatment. Using special light-emitting diodes (LEDs), the neoBLUE mini device emits blue light, which is clinically proven to be most effective in the breakdown of bilirubin and treatment of newborn jaundice(1).

Jim Hawkins, President and Chief Executive Officer of Natus, commented, "With its small size and flexible mounting options, the neoBLUE mini is well-suited for a variety of patient care settings. More importantly, the neoBLUE system allows clinicians to comply with the recently published American Academy of Pediatrics guidelines for phototherapy(2). We are also excited to introduce this product at a lower price point, which we believe will be an excellent value to our customers."